All Stories

  1. Oncogenic activation of PIK3CA in cancers: Emerging targeted therapies in precision oncology

    Article • Genes & Diseases, March 2025, Tsinghua University Press

    Zhenghe Wang

  2. An immune checkpoint molecule regulated by a putative dead enzyme.

    Article • Genes & Diseases, July 2023, Tsinghua University Press

    Zhenghe Wang

  3. Nuclear translocation of p85β promotes tumorigenesis of PIK3CA helical domain mutant cancer

    Article • Nature Communications, April 2022, Springer Science + Business Media

    Zhenghe Wang

  4. Deep proteomic analysis of Dnmt1 mutant/hypomorphic colorectal cancer cells reveals dysregulation of epithelial–mesenchymal transition and subcellular re-localization of Beta-Catenin

    Article • Epigenetics, August 2019, Taylor & Francis

    Zhenghe Wang

  5. ELF3 is an antagonist of oncogenic-signalling-induced expression of EMT-TF ZEB1

    Article • Cancer Biology & Therapy, August 2018, Taylor & Francis

    Rachel Harris, Zhenghe Wang